NMD UP!

Quote






TOTAL BS - IT is DRG THAT SPIKED THE NUMBERS - FACT

NOT BURST THAT IMPROVED NUMBERS IT WAS SPINAL MODULATION SALES - FACT

BURST FAILED COMMERCIAL SUCCESS AND STUDY, LESS THEN 50% SUCCESS AND DID NOT EVEN BEAT BSC- FACT

BURST FAILED - FACT
 






wow this sounds really bad and typical of sjm as they share batteries with nmd -


St. Jude Medical (NYSE:STJ) today warned of the possibility that a battery issue could disable its high-voltage cardiac rhythm management devices, saying the problem is associated with 2 deaths among the nearly 400,000 patients implanted with affected devices.

The news broke last night with a Twitter post by notorious short-selling firm Muddy Waters Consulting containing a copy of the letter St. Jude sent today detailing the problem. Muddy Waters and a cybersecurity firm in August alleged that major flaws in St. Jude’s CRM devices exposed them to a cybersecurity risk, but only after taking short positions on STJ’s stock. St. Jude later sued Muddy Waters and the hacking shop behind the report, after the sides traded accusations about its accuracy (which independent researchers found had “major flaws” – but not before STJ shares lost about 5% of their value, although the stock had mostly recovered as of the market’s close last week).

Today St. Jude said that there’s a risk that the lithium-based batteries used in its implantable cardioverter defibrillators and cardiac resynchronization therapy devices could form “lithium clusters” during high-voltage charging. The clusters could then cause a short circuit and deplete the battery within a day to a few weeks, rendering the device incapable of delivering therapy. The company said it received reports of 841 devices with the premature battery depletion issue among the 398,470 Fortify, Fortify Assura, Quadra Assura, Quadra Assura MP, Unify, Unify Assura and Unify Quadra devices it’s sold worldwide (roughly 0.21%), including the 2 deaths “associated with the loss of defibrillation therapy as a result of premature battery depletion.” The problem affects ICDs and CRT-Ds made before May 23, 2015, Little Canada, Minn.-based St. Jude said.

The company is recommending that patients contact their doctors immediately if their high-voltage
 






nice work sjm

St. Jude Medical (NYSE:STJ) today warned of the possibility that a battery issue could disable its high-voltage cardiac rhythm management devices, saying the problem is associated with 2 deaths among the nearly 400,000 patients implanted with affected devices.

The news broke last night with a Twitter post by notorious short-selling firm Muddy Waters Consulting containing a copy of the letter St. Jude sent today detailing the problem. Muddy Waters and a cybersecurity firm in August alleged that major flaws in St. Jude’s CRM devices exposed them to a cybersecurity risk, but only after taking short positions on STJ’s stock. St. Jude later sued Muddy Waters and the hacking shop behind the report, after the sides traded accusations about its accuracy (which independent researchers found had “major flaws” – but not before STJ shares lost about 5% of their value, although the stock had mostly recovered as of the market’s close last week).

Today St. Jude said that there’s a risk that the lithium-based batteries used in its implantable cardioverter defibrillators and cardiac resynchronization therapy devices could form “lithium clusters” during high-voltage charging. The clusters could then cause a short circuit and deplete the battery within a day to a few weeks, rendering the device incapable of delivering therapy. The company said it received reports of 841 devices with the premature battery depletion issue among the 398,470 Fortify, Fortify Assura, Quadra Assura, Quadra Assura MP, Unify, Unify Assura and Unify Quadra devices it’s sold worldwide (roughly 0.21%), including the 2 deaths “associated with the loss of defibrillation therapy as a result of premature battery depletion.” The problem affects ICDs and CRT-Ds made before May 23, 2015, Little Canada, Minn.-based St. Jude said.

The company is recommending that patients contact their doctors immediately if their high-voltage
 






anonymous said:
wow this sounds really bad and typical of sjm as they share batteries with nmd -


St. Jude Medical (NYSE:STJ) today warned of the possibility that a battery issue could disable its high-voltage cardiac rhythm management devices, saying the problem is associated with 2 deaths among the nearly 400,000 patients implanted with affected devices.

The news broke last night with a Twitter post by notorious short-selling firm Muddy Waters Consulting containing a copy of the letter St. Jude sent today detailing the problem. Muddy Waters and a cybersecurity firm in August alleged that major flaws in St. Jude’s CRM devices exposed them to a cybersecurity risk, but only after taking short positions on STJ’s stock. St. Jude later sued Muddy Waters and the hacking shop behind the report, after the sides traded accusations about its accuracy (which independent researchers found had “major flaws” – but not before STJ shares lost about 5% of their value, although the stock had mostly recovered as of the market’s close last week).

Today St. Jude said that there’s a risk that the lithium-based batteries used in its implantable cardioverter defibrillators and cardiac resynchronization therapy devices could form “lithium clusters” during high-voltage charging. The clusters could then cause a short circuit and deplete the battery within a day to a few weeks, rendering the device incapable of delivering therapy. The company said it received reports of 841 devices with the premature battery depletion issue among the 398,470 Fortify, Fortify Assura, Quadra Assura, Quadra Assura MP, Unify, Unify Assura and Unify Quadra devices it’s sold worldwide (roughly 0.21%), including the 2 deaths “associated with the loss of defibrillation therapy as a result of premature battery depletion.” The problem affects ICDs and CRT-Ds made before May 23, 2015, Little Canada, Minn.-based St. Jude said.

The company is recommending that patients contact their doctors immediately if their high-voltage
Click to expand...
 












anonymous said:
SJM launched Burst stimulation overseas more than one year ago - FACT
Financial result for NMD are great, and it is 3 o 4 quarter in a row the ID franchise hit a double digit growth - FACT
So at this point you have 2 options:
1) Customers are idiots and use Burst because they like to lobotomize their patients so you are right
2) You should spend your time selling Burst instead of blaming your Company because it works
It is your choice morons...
Click to expand...

Where is the actual data (pain scores, statistical significance, etc.) from the Sunburst study published? All I can find are unsubstantiated claims and talking points from SJM consultants.
 






























25% of us are hitting our stim quota so I hope Burst helps the others hit plan. Thank you to Keith for having the foresight to acquire Spinal Modulation as that is helping a lot of us this year. However, on Neurotherm was a garbage purchase riddled with service and issues.
 






anonymous said:
25% of us are hitting our stim quota so I hope Burst helps the others hit plan. Thank you to Keith for having the foresight to acquire Spinal Modulation as that is helping a lot of us this year. However, on Neurotherm was a garbage purchase riddled with service and issues.
Click to expand...

Burst is a big lie and it's only a matter of time before even hardcore SJM docs face up to it. DRG is a solid therapy but it's never going to be widely adopted. Like the optimism though...
 












anonymous said:
spoken like a scared NEVRO rep
Click to expand...


that is so funny, if burst is so good why dosent it beat conventional scs? Why not go head to head with a full 24 month RCt study against HF10? Why not, because burst is dangerous and harms patients, it does not meet any clinical criteria and is a confirmed failure. The only ones selling burst is the docs making money - Dr Deer and Dr Derobber - both slick salesman that don't give a shit about quality data or patients.

SJM is a very unethical, non clinical piece of shit company. If your there plan on getting wiped out because Abbott is actually a Great company and they smell and see a big turd in the punch bowel with exec team from SJM NMD! SJM breaks every rule in the business, just look at the sunshine act, DR Deer made $900,000.00 dollars selling Burst and others like him; who's knocking on the door? DOJ

Good luck finding a job next year
SCS Market
 






anonymous said:
that is so funny, if burst is so good why dosent it beat conventional scs? Why not go head to head with a full 24 month RCt study against HF10? Why not, because burst is dangerous and harms patients, it does not meet any clinical criteria and is a confirmed failure. The only ones selling burst is the docs making money - Dr Deer and Dr Derobber - both slick salesman that don't give a shit about quality data or patients.

SJM is a very unethical, non clinical piece of shit company. If your there plan on getting wiped out because Abbott is actually a Great company and they smell and see a big turd in the punch bowel with exec team from SJM NMD! SJM breaks every rule in the business, just look at the sunshine act, DR Deer made $900,000.00 dollars selling Burst and others like him; who's knocking on the door? DOJ

Good luck finding a job next year
SCS Market
Click to expand...
Mothers of stupids is always pregnant......luckily customers are more clever than you and 8 quarter in a row of double digit growht is the mirror of reality!!
 






anonymous said:
Mothers of stupids is always pregnant......luckily customers are more clever than you and 8 quarter in a row of double digit growht is the mirror of reality!!
Click to expand...

that is such crap, you buy spinal and say your growing - your a tool and an idiot ready to get wiped out

it is great to see you this nervous and this weak
 
























Top Bottom
Back
Quote